Page last updated: 2024-11-02

pioglitazone and B16 Melanoma

pioglitazone has been researched along with B16 Melanoma in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fu, S1
He, K1
Tian, C1
Sun, H1
Zhu, C1
Bai, S1
Liu, J1
Wu, Q1
Xie, D1
Yue, T1
Shen, Z1
Dai, Q1
Yu, X1
Zhu, S1
Liu, G1
Zhou, R1
Duan, S1
Tian, Z1
Xu, T1
Wang, H1
Bai, L1
Mori, A1
Sakurai, H1
Choo, MK1
Obi, R1
Koizumi, K1
Yoshida, C1
Shimada, Y1
Saiki, I1

Other Studies

2 other studies available for pioglitazone and B16 Melanoma

ArticleYear
Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells.
    Nature communications, 2020, 01-23, Volume: 11, Issue:1

    Topics: Animals; Carcinoma, Hepatocellular; Cholesterol; Galactosylceramides; Gene Expression Regulation; Hu

2020
Severe pulmonary metastasis in obese and diabetic mice.
    International journal of cancer, 2006, Dec-15, Volume: 119, Issue:12

    Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Hypoglycemic Agents; Killer Cells, Natural; Leptin

2006